Terms: = Ovarian cancer AND NCKIPSD, AF3P21, 51517, ENSG00000213672, SPIN90, WASLBP, Q9NZQ3, WISH, ORF1 AND Treatment
151 results:
1. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
[TBL] [Abstract] [Full Text] [Related]
2. Patient-reported outcome measures (PROMs) to personalise follow-up care of ovarian cancer: what do patients think? A qualitative interview study.
Seeratan DD; van Schuylenburch RG; van Lonkhuijzen LRCW; Aarts JWM
Support Care Cancer; 2024 Mar; 32(4):247. PubMed ID: 38528152
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
Shibahara M; Kurita T; Harada H; Tsuda Y; Hisaoka M; Yoshino K
Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():1-7. PubMed ID: 38310674
[TBL] [Abstract] [Full Text] [Related]
4. Uterine Tumors Resembling ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases.
Watrowski R; Palumbo M; Guerra S; Gallo A; Zizolfi B; Giampaolino P; Bifulco G; Di Spiezio Sardo A; De Angelis MC
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276058
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
[TBL] [Abstract] [Full Text] [Related]
7. Approaches to Fertility Preservation for Young Women With Breast cancer.
Razeti MG; Soldato D; Arecco L; Levaggi A; Puglisi S; Solinas C; Agostinetto E; Spinaci S; Lapuchesky L; Genova C; Massarotti C; Lambertini M
Clin Breast Cancer; 2023 Apr; 23(3):241-248. PubMed ID: 36710145
[TBL] [Abstract] [Full Text] [Related]
8. Survey of understanding and awareness of fertility preservation in pediatric patients: Is conversation about fertility preservation unpleasant for pediatric patients?
Takae S; Iwahata Y; Sugishita Y; Iwahata H; Kanamori R; Shiraishi E; Ito K; Suzuki Y; Yamaya Y; Tanaka K; Oyama K; Keino D; Nakamura K; Odawara K; Horage Y; Meng L; Igualada A; Faizal AM; Aworet LO; Furuta S; Sakamoto M; Mori T; Kitagawa H; Suzuki N
Front Endocrinol (Lausanne); 2022; 13():1074603. PubMed ID: 36686445
[TBL] [Abstract] [Full Text] [Related]
9. Endometrial cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Peng H; Jiang J; Li X
Reprod Sci; 2022 Nov; 29(11):3278-3284. PubMed ID: 35641856
[TBL] [Abstract] [Full Text] [Related]
10. High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis.
Yan L; Huang H; Lin J; Yu R
Int J Hyperthermia; 2022; 39(1):230-238. PubMed ID: 35094613
[TBL] [Abstract] [Full Text] [Related]
11. Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC).
Fotopoulou C; Rockall A; Lu H; Lee P; Avesani G; Russo L; Petta F; Ataseven B; Waltering KU; Koch JA; Crum WR; Cunnea P; Heitz F; Harter P; Aboagye EO; du Bois A; Prader S
Br J Cancer; 2022 Apr; 126(7):1047-1054. PubMed ID: 34923575
[TBL] [Abstract] [Full Text] [Related]
12. ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
Monk BJ; Coleman RL; Fujiwara K; Wilson MK; Oza AM; Oaknin A; O'Malley DM; Lorusso D; Westin SN; Safra T; Herzog TJ; Marmé F; N Eskander R; Lin KK; Shih D; Goble S; Grechko N; Hume S; Maloney L; McNeish IA; Kristeleit RS
Int J Gynecol Cancer; 2021 Dec; 31(12):1589-1594. PubMed ID: 34593565
[TBL] [Abstract] [Full Text] [Related]
13. Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study.
Melin J; Tiitinen A; Hirvonen E; Malila N; Pitkäniemi J; Gissler M; Madanat-Harjuoja L
Hum Reprod; 2021 Nov; 36(12):3131-3140. PubMed ID: 34491339
[TBL] [Abstract] [Full Text] [Related]
14. Assisted Reproductive Techniques and submucous myoma.
Nikbakht R; Dorfeshan P
JBRA Assist Reprod; 2021 Oct; 25(4):650-652. PubMed ID: 34415133
[TBL] [Abstract] [Full Text] [Related]
15. Clinical investigation of fertility after uterine artery embolization.
Serres-Cousine O; Kuijper FM; Curis E; Atashroo D
Am J Obstet Gynecol; 2021 Oct; 225(4):403.e1-403.e22. PubMed ID: 34058169
[TBL] [Abstract] [Full Text] [Related]
16. Retrospective analysis of clinicopathological characteristics of 19 ovarian juvenile granulosa cell tumor cases.
Ndhlovu E; Liu L; Dai J; Dong X; Zhang W; Chen B
J Obstet Gynaecol Res; 2021 Jul; 47(7):2492-2499. PubMed ID: 33904645
[TBL] [Abstract] [Full Text] [Related]
17. Fertility and pregnancy outcome in gestational trophoblastic disease.
Joneborg U; Coopmans L; van Trommel N; Seckl M; Lok CAR
Int J Gynecol Cancer; 2021 Mar; 31(3):399-411. PubMed ID: 33649007
[TBL] [Abstract] [Full Text] [Related]
18. Fertility sparing surgery for early-stage clear cell carcinoma of the ovary; A systematic review and analysis of obstetric outcomes.
Prodromidou A; Theofanakis C; Thomakos N; Haidopoulos D; Rodolakis A
Eur J Surg Oncol; 2021 Jun; 47(6):1286-1291. PubMed ID: 33509613
[TBL] [Abstract] [Full Text] [Related]
19. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract] [Full Text] [Related]
20. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract] [Full Text] [Related]
[Next]
